To identify and develop innovative and breakthrough
pharmaceutical products for diseases that remain
unconquered as yet
NewsList
-
- 22 March, 2024Licensing
- Ono Pharmaceutical Co., Ltd. Enters into Comprehensive Drug Discovery Collaboration Agreement with University of Oxford
-
- 14 March, 2024Licensing
- Ono Pharmaceutical Co., Ltd. Enters into a Collaboration Agreement with Sibylla Biotech to Generate Novel Drug Candidates for Neurological Disorders
-
- 14 February, 2024Licensing
- Ono Pharmaceutical Co., Ltd. Enters into an Option and Collaboration Agreement with Numab to Develop Multi-specific Antibody NM49